about
Artificial Blood Substitutes: First Steps on the Long Route to Clinical UtilityInduction of multipotency in umbilical cord-derived mesenchymal stem cells cultivated under suspension conditions.In vitro augmentation of mesenchymal stem cells viability in stressful microenvironments : In vitro augmentation of mesenchymal stem cells viabilityAdenovirus-Mediated Over-Expression of Nrf2 Within Mesenchymal Stem Cells (MSCs) Protected Rats Against Acute Kidney Injury.Nrf-2 overexpression in mesenchymal stem cells reduces oxidative stress-induced apoptosis and cytotoxicityFunctional recombinant extra membrane loop of human CD20, an alternative of the full length CD20 antigenLipocalin-2-mediated upregulation of various antioxidants and growth factors protects bone marrow-derived mesenchymal stem cells against unfavorable microenvironmentsBiologically Active Heterocyclic Hybrids Based on Quinazolinone, Benzofuran and Imidazolium Moieties: Synthesis, Characterization, Cytotoxic and Antibacterial Evaluation.Exposition of hepatitis B surface antigen (HBsAg) on the surface of HEK293T cell and evaluation of its expression.In silico and in vivo studies of truncated forms of flagellin (FliC) of enteroaggregative Escherichia coli fused to FimH from uropathogenic Escherichia coli as a vaccine candidate against urinary tract infections.Attempts to express the A1-GMCSF immunotoxin in the baculovirus expression vector system.Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI.In Silico and In Vitro Studies of Truncated Forms of Flagellin (FliC) of Enteroaggregative Escherichia coli (EAEC).Expression of HCV Alternative Reading Frame Protein (Core+1/F) in Baculovirus Expression System and its Evaluation for Assessment of Specific Anti-core+1 Antibody in Iranian HCV Infected Patients.Synthesis and antimicrobial evaluation of some 2,5 disubstituted 1,3,4-oxadiazole derivatives.Expression and purification of truncated diphtheria toxin, DT386, in Escherichia coli: An attempt for production of a new vaccine against diphtheria.Recombinant human lipocalin 2 acts as an antibacterial agent to prevent platelet contamination.Docking study, synthesis and antimicrobial evaluation of some novel 4-anilinoquinazoline derivatives.Lipocalin 2 decreases senescence of bone marrow-derived mesenchymal stem cells under sub-lethal doses of oxidative stress.HIF-1α confers resistance to induced stress in bone marrow-derived mesenchymal stem cells.Synthesis and evaluation of antimicrobial activity of cyclic imides derived from phthalic and succinic anhydrides.Biological evaluation, docking and molecular dynamic simulation of some novel diaryl urea derivatives bearing quinoxalindione moiety.Poly (butylene adipate-co-butylene terephthalate) nanoparticles prepared by electrospraying technique for docetaxel delivery in ovarian cancer induced mice.Enhanced solubility, oral bioavailability and anti-osteoporotic effects of raloxifene HCl in ovariectomized rats by Igepal CO-890 nanomicelles.Synthesis and characterization of some novel diaryl urea derivatives bearing quinoxalindione moiety.A novel mixed polymeric micelle for co-delivery of paclitaxel and retinoic acid and overcoming multidrug resistance: synthesis, characterization, cytotoxicity, and pharmacokinetic evaluation.Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex® nanoparticles for docetaxel delivery in ovarian cancer.Luteinizing hormone-releasing hormone targeted poly(methyl vinyl ether maleic acid) nanoparticles for doxorubicin delivery to MCF-7 breast cancer cells.Targeted Delivery of Docetaxel by Use of Transferrin/Poly(allylamine hydrochloride)-functionalized Graphene Oxide Nanocarrier.Production and evaluation of cytotoxic effects of DT386-BR2 fusion protein as a novel anti-cancer agent.Recombinant expression and purification of functional vascular endothelial growth factor-121 in the baculovirus expression system.Lipocalin 2 enhances mesenchymal stem cell-based cell therapy in acute kidney injury rat model.Antigenicity and immunogenicity of fused B-subunit of heat labile toxin of Escherichia coli and colonization factor antigen I polyepitopes.Preparation and Characterization of Spray-Dried Inhalable Powders Containing Polymeric Micelles for Pulmonary Delivery of Paclitaxel in Lung CancerCo-culture of bone marrow-derived mesenchymal stem cells overexpressing lipocalin 2 with HK-2 and HEK293 cells protects the kidney cells against cisplatin-induced injuryTherapeutic Targeting of Chemokines and Chemokine Receptors in Multiple Sclerosis: Opportunities and ChallengesExpression and one step intein-mediated purification of biologically active human G-CSF in Escherichia coliEfavirenz oral delivery via lipid nanocapsules: formulation, optimisation, and ex-vivo gut permeation studyA-NGR fusion protein induces apoptosis in human cancer cellsChronic Oral Arsenic Exposure and Its Correlation with Serum S100B Concentration
P50
Q28075789-8EAF75D6-8A76-4161-813B-8404CA8BEC5AQ34099882-755E5EF5-4DD1-4825-8864-E563627C2B60Q35078827-1777A81C-94AB-4D95-9381-D67AD04FDDEFQ35895250-75ED135B-3D6B-467E-8909-857A9FC3C964Q36502594-B84A41CA-B5CB-4DE9-A598-4A6924DDEA67Q36777171-AAAF27BF-46FC-4F3E-ACC7-E0BC3B0F2533Q37213588-EA7D0953-F8DF-421B-B60F-4DFDCA595199Q38724968-B0762BC8-79B0-4CA3-9B22-37E41B408517Q38727491-3658789E-FD7E-4C1A-880C-7634854D48E1Q39023638-57F36090-A027-4D4A-8CC9-7C7BDCF01559Q39367729-D4EA0A10-721E-4EDB-B84A-979890300AA1Q39439840-BF4F7838-304F-4F8F-BAEF-3E01E324D5E4Q39537395-986CA8EE-D453-48B0-BC4A-26126E32A904Q40344065-81A75C0D-F957-4A8E-8093-CC095A1E9F41Q41480866-02AA9442-0A64-4EF2-8543-D617D7A8AA85Q41870925-797EB7FC-A7ED-49B2-B2EA-387C15F3C8B9Q42226584-969DFEFF-58CA-457F-9EEA-0819DA67DE9AQ42364823-9D242EB0-B6BA-4702-AC45-53DA3099673CQ42846745-01310E8D-ADF8-47BA-903C-4AAFE580AB7AQ44493494-A30128F8-5A78-4046-B623-A777B3E263D4Q46894500-24962D2D-1C17-48AB-9E5B-887D333735D1Q47109385-2EC2D9DC-8934-4646-A844-67977D34FFBDQ48217379-643DC67F-B240-48E5-942F-E386CCF243B2Q48233442-6B71C9A7-8F26-412D-BD20-0807CD0AFD35Q49308131-D550AE7B-7BAB-4851-90D4-AAACAD92961CQ49857972-F606D01D-DB33-40A8-90D6-131E52203752Q50054796-6BD21EE8-17EE-4D7F-86BB-0E5D65BF904EQ50198769-4B777EAF-0BFC-4587-BEE7-8C236D2FC126Q51340002-5000FEC2-A76B-436A-A182-144117BB1CDBQ51526750-C40B20BF-5850-498C-BC66-2C538EF51990Q52860846-0E40B924-0B47-4BEC-8B7F-0C5E56E994F5Q53251299-AC1FE9AA-B384-457A-AD91-D678402A840BQ54284027-16BE4EC7-C058-4C80-93F5-389901416AA5Q57498384-7A8350F4-182C-4C6C-A221-E8C03FA0B015Q57714141-1AAAF4C9-25E0-4744-A98D-D4BBA4EAD4D4Q90023638-FB7FC24A-F832-4E86-8705-03CF9265F0CDQ90751116-436CE29D-1520-4497-A9EF-A50157289982Q90927518-E802A417-F478-47DA-A48A-0CE2DC06900FQ90947940-E221C153-C975-4937-A240-DFC364751644Q90953911-543CDC27-4888-491C-B294-23DBA426CAD1
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Ali Jahanian-Najafabadi
@en
Ali Jahanian-Najafabadi
@nl
type
label
Ali Jahanian-Najafabadi
@en
Ali Jahanian-Najafabadi
@nl
prefLabel
Ali Jahanian-Najafabadi
@en
Ali Jahanian-Najafabadi
@nl
P31
P496
0000-0001-9538-8260